Pay in 4 interest-free payments of $5.86 Learn more
Ships within 48 hours · Estimated delivery Sep 4 - Sep 9
Due to their high biocompatibility and strong bioactivity, sEVs act as a promising tool for therapeutic delivery strategies in cancer therapy
Published in November 2020
FDA-approved (October 2019) as SCENESSE for adults with EPP Regulations vary by country and may change
An important point upfront: several of the compounds discussed below are not currently licensed as medicines by the UAE Ministry of Health, the Department of Health Abu Dhabi (DOH), the FDA or other national regulators
PMID: 10 HuttaschMRodenMKahlS
US$ 24.15
US$ 27.61
US$ 25.32
US$ 27.67
US$ 21.18
